Abstract:Abnormal elongation of the polyglutamine tract transforms exon 1 of the Huntingtin protein (Htt-exon-1) from wildtype to pathogenic form, and causes Huntington's disease. As an intrinsically disordered protein, the structural ensemble of Htt-exon-1 is highly heterogeneous and the detailed conformation of toxic species is still under debate. Ispinesib, a potential small-molecule drug, has been identified to selectively link the pathogenic Htt-exon-1 into the autophagosome to degrade, thus opening an innovative therapeutic direction. However, the molecular mechanisms behind this selectivity remain largely elusive. Herein, we carry out extensive molecular dynamics simulations with an enhanced sampling method to investigate the ispinesib inducing conformational changes of pathogenic and wildtype Htt-exon-1 and the corresponding binding mechanisms. Our simulations reveal that the ispinesib binding induces opposite conformational changes in pathogenic and wildtype Htt-exon-1, i.e., the 'entropy collapse' with significant reduction of β-sheets versus the 'entropy expansion' with a slight increase of α-helices. Network analyses further reveal that there are two stable binding sites in the pathogenic Htt-exon-1, while the binding on the wildtype Htt-exon-1 is highly dynamic and non-specific. These dramatic differences originate from the underlying distinct binding interactions. More specifically, stronger hydrogen bonds serve as the specific binding anchors in pathogenic Htt-exon-1, while stronger hydrophobic interactions dominate in the dynamic binding with wildtype Htt-exon-1. Our simulations provide an atomistic mechanism for the ispinesib selective binding on the pathogenic Htt-exon-1, and further shed light on the general mechanisms of small molecule modulation on intrinsically disordered proteins.

Alternative splicing affecting the SH3A domain controls the binding properties of intersectin 1 in neurons

Alternative splicing controls teneurin-3 compact dimer formation for neuronal recognition

Alternative splicing at GYNNGY 5' splice sites: more noise, less regulation.

Intron-targeted mutagenesis reveals roles for<i>Dscam1</i>RNA pairing-mediated splicing bias in neuronal wiring

Intron-targeted mutagenesis reveals roles for Dscam1 RNA pairing-mediated splicing bias in neuronal wiring

Intron-targeted mutagenesis reveals roles for <i>Dscam1</i> RNA pairing architecture-driven splicing bias in neuronal wiring

Alternative translation initiation produces synaptic organizer proteoforms with distinct localization and functions

The Interplay Between Splicing of Two Exon Combinations Differentially Affects Membrane Targeting and Function of Human CaV2.2

Trans-splicing facilitated by RNA pairing greatly expands sDscam isoform diversity but not homophilic binding specificity

N-terminal alternative splicing of GluN1 regulates the maturation of excitatory synapses and seizure susceptibility.

Increased Dysbindin-1B Isoform Expression in Schizophrenia and Its Propensity in Aggresome Formation

Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex

Intersectin - many facets of a scaffold protein

Alternative splicing across the nervous system

Regulation of alternative splicing and polyadenylation in neurons

Alternative Splicing of Disabled-1 Controls Multipolar-to-Bipolar Transition of Migrating Neurons in the Neocortex

Alternative splice isoforms of small conductance calcium-activated SK2 channels differ in molecular interactions and surface levels

Distinct Binding Interactions Trigger Opposite Conformational Modulations on Pathogenic and Wildtype Huntingtin Exon 1 Proteins

Effects of Nt-truncation and coexpression of isolated Nt domains on the membrane trafficking of electroneutral Na + /HCO 3 – cotransporters

Tissue Usage Preference and Intrinsically Disordered Region Remodeling of Alternative Splicing Derived Proteoforms in the Heart

Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation